The sustained BAD-LAMP expression in breast tumour-associated pDCs is therefore likely to contribute to the lack of IFN-α production, a dysfunctional phenotype generally associated with immune tolerance and aggressive cancer29, 30. This evidence concerns the gene IFNA2 and breast neoplasm.